Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
New report raises questions about data that helped heart drug gain FDA approval
Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

Time for a change? AFib patients may want to stop drinking alcohol

Alcohol consumption is associated with a heightened risk of stroke among patients with newly diagnosed atrial fibrillation.

How later COVID-19 surges impacted heart attack and stroke numbers

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

FDA announces recall of more than 30,000 Boston Scientific stent systems after numerous injuries

In total, the recall affects 31,798 venous stent systems distributed to customers from September 2018 to April 2021.

High blood pressure linked to greater risk of heart failure, AFib, heart attack, stroke

The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation.

How to diagnose and treat rare blood clots associated with a COVID-19 vaccine

The team behind the new guidance also emphasized how important it still is for all adults to get vaccinated.

FDA authorizes brain-computer interface for stroke patients

The FDA has also indicated it is “establishing special controls for devices of this type,” including labeling and testing requirements.

‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk

The median time from a positive serological test result to acute ischemic stroke was nearly 55 days.

How patient care changes when stroke centers offer endovascular thrombectomy

Researchers simulated more than 80 million patient encounters, running a variety of models to gain as much insight as possible.

Vascular & Endovascular

New guidelines help interventional cardiologists manage chronic venous disease

Private equity firm jumps into vascular health with new investment

New report raises questions about data that helped heart drug gain FDA approval

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

Angiographic catheters recalled due to safety risk